Cargando…
EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2-GSK3β-dependent MPTP inhibition
Prostaglandin E receptor subtype 4 (EP4) is widely distributed in the heart, but its role in hepatic ischemia/reperfusion (I/R), particularly in mitochondrial permeability transition pore (MPTP) modulation, is yet to be elucidated. In the present study, an EP4 agonist (CAY10598) was used in a rat mo...
Autores principales: | Cai, Lin-Lin, Xu, Hai-Tao, Wang, Qi-Long, Zhang, Ya-Qing, Chen, Wei, Zheng, Dong-Yu, Liu, Fang, Yuan, Hong-Bin, Li, Yong-Hua, Fu, Hai-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169940/ https://www.ncbi.nlm.nih.gov/pubmed/32186754 http://dx.doi.org/10.3892/ijmm.2020.4544 |
Ejemplares similares
-
Apelin-13 protects the heart against ischemia-reperfusion injury through the RISK-GSK-3β-mPTP pathway
por: Yang, Shuansuo, et al.
Publicado: (2015) -
Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
por: Wang, Xiaoping, et al.
Publicado: (2021) -
Gsk3β regulates the resolution of liver ischemia/reperfusion injury via MerTK
por: Zhang, Hanwen, et al.
Publicado: (2023) -
GSK3β Exacerbates Myocardial Ischemia/Reperfusion Injury by Inhibiting Myc
por: Wen, Cong, et al.
Publicado: (2022) -
Attenuation of hepatic ischemia-reperfusion injury by adipose stem cell-derived exosome treatment via ERK1/2 and GSK-3β signaling pathways
por: Zhang, Yaqing, et al.
Publicado: (2022)